We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.31B
AUM Growth
+$305M
Cap. Flow
+$338M
Cap. Flow %
25.88%
Top 10 Hldgs %
40.19%
Holding
87
New
20
Increased
35
Reduced
4
Closed
23

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.6M
2
SGI
Somnigroup International
SGI
+$37.3M
3
AMAG
AMAG Pharmaceuticals
AMAG
+$32.2M
4
PRKS icon
United Parks & Resorts
PRKS
+$29.4M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$27.3M

Top Sells

Rank Stock Value
1
ENR icon
Energizer
ENR
+$29.4M
2
CMG icon
Chipotle Mexican Grill
CMG
+$22.5M
3
GSK icon
GSK
GSK
+$14.6M
4
GME icon
GameStop
GME
+$14.4M
5
BJRI icon
BJ's Restaurants
BJRI
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 42.21%
2 Consumer Discretionary 25.02%
3 Consumer Staples 9.24%
4 Financials 1.15%
5 Technology 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$147M 11.27%
560,000
– –
AVTX icon
2
Avalo Therapeutics
AVTX
$976M
$68.9M 5.27%
5,573
– –
VNDA icon
3
Vanda Pharmaceuticals
VNDA
$312M
$43.8M 3.35%
2,600,000
-78,000
-3% -$1.31M
UTHR icon
4
United Therapeutics
UTHR
$26.3B
$43.6M 3.33%
388,000
+188,000
+94% +$23.9M
FRPT icon
5
Freshpet
FRPT
$2.83B
$39.7M 3.04%
2,416,000
+1,124,000
+87% +$20.8M
AMAG
6
DELISTED
AMAG Pharmaceuticals
AMAG
$38.4M 2.93%
+1,904,000
New +$32.2M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$68.8B
$37.2M 2.84%
+108,000
New +$37.6M
HBI
8
DELISTED
Hanesbrands
HBI
$36.8M 2.82%
2,000,000
+600,000
+43% +$12.4M
ASRT
9
DELISTED
Assertio
ASRT
$35.4M 2.71%
89,583
+28,616
+47% +$12.5M
PZZA icon
10
CALL
Papa John's
PZZA
$999M
$34.4M 2.63%
600,000
+150,000
+33% +$8.98M
CAKE icon
11
Cheesecake Factory
CAKE
$4.21B
$33.8M 2.58%
700,000
+300,000
+75% +$14.4M
HOG icon
12
Harley-Davidson
HOG
$2.68B
$31.2M 2.39%
728,000
+344,000
+90% +$16.5M
SGI
13
Somnigroup International
SGI
$15.1B
$30.8M 2.36%
+2,720,000
New +$37.3M
CVS icon
14
CVS Health
CVS
$137B
$30.6M 2.34%
492,000
+292,000
+146% +$21M
HAIN icon
15
CALL
Hain Celestial
HAIN
$47.8M
$30.2M 2.31%
942,300
-157,700
-14% -$5.73M
PLYA
16
DELISTED
Playa Hotels & Resorts
PLYA
$30M 2.29%
2,936,000
+712,000
+32% +$7.44M
SBBP
17
DELISTED
Strongbridge Biopharma plc.
SBBP
$29.8M 2.28%
3,372,000
+502,000
+17% +$3.76M
POST icon
18
Post Holdings
POST
$4.12B
$29.7M 2.27%
598,976
+122,240
+26% +$6.18M
PRKS icon
19
United Parks & Resorts
PRKS
$2.11B
$29.7M 2.27%
+2,000,000
New +$29.4M
ATRS
20
DELISTED
Antares Pharma, Inc.
ATRS
$27.6M 2.11%
12,560,000
+4,960,000
+65% +$11.2M
CPB icon
21
Campbell Soup
CPB
$6.51B
$27.2M 2.08%
628,000
+20,000
+3% +$901K
UAA icon
22
Under Armour
UAA
$3B
$24.9M 1.9%
1,520,000
+120,000
+9% +$1.88M
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
$24.7M 1.89%
+468,000
New +$27.3M
SAM icon
24
Boston Beer
SAM
$1.88B
$24.2M 1.85%
128,000
+64,000
+100% +$11.8M
PCRX icon
25
Pacira BioSciences
PCRX
$1.02B
$22.6M 1.73%
726,671
+398,671
+122% +$14.2M
1
2 3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Armistice Capital held 87 positions worth $1.31B, up 30% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $338M of net new capital in Q1 2018, opening 20 new positions and adding to 35 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 108,000 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Vanda Pharmaceuticals, an estimated $1.31M trimmed.

  • Armistice Capital's largest Q1 2018 buy was Regeneron Pharmaceuticals: 108,000 shares worth $37.2M.
  • Armistice Capital added most to United Therapeutics in Q1 2018, an estimated $23.9M increase.
  • Armistice Capital's biggest Q1 2018 reduction was Vanda Pharmaceuticals, cutting an estimated $1.31M.
  • Armistice Capital fully exited Energizer in Q1 2018, selling an estimated $29.4M.
  • Armistice Capital's ten largest holdings make up 40% of its $1.31B portfolio in Q1 2018.
  • Armistice Capital opened 20 new positions and closed 23 in Q1 2018.
  • Armistice Capital's portfolio value rose 30% quarter-over-quarter to $1.31B.

Based on Armistice Capital's 13F filing for Q1 2018, filed 15 May 2018.